Breaking News
Who's scored a seat on the Medicines Australia Board?
Medicines Australia has named two high-profile company leaders as the newest additions to the Board, after Country Leadership changes mid-year resulted in departures
Featured
Is it time for pharma to boycott PBAC?
A high-profile former Senior Health Department official turned patient advocate has called on the pharmaceutical industry to force the Government to take HTA reform seriously by withholding all submissions from the PBAC
Regulatory & Reimbursement
Sept PBAC: Winners and Losers
Two out of three companies hoping to cut a path to a broad listing were told the preliminary info they provided didn't cut it, according to outcomes from September's Intracycle Meeting
Regulatory & Reimbursement
Second generic targets $113M drug
A second company has registered a copycat of a cancer drug across all tablet blister strengths, turning up the heat on the originator brand
Industry & Companies
It's official: this Aussie pharma knows how to celebrate
Recognised as a Great Place to Work for the fifth time, this company blitzed the benchmarks across four measures with a standout result for celebrating special events.
Featured
How much do pharmas earn in Australia?
A report released by the ATO has revealed the total income declared in Australia for all pharmas who brought in at least a hundred million dollars. See the list
Industry & Companies
Pharmas go on $11B buying binge
Five companies have splashed cash on new assets to build out their current portfolios, with one hoping a Virtual Human AI platform will uncover transformative therapeutics
Regulation & Legal
HCP bungles trigger updates to two vaccine PIs
Product information updates for two jabs after reports of incorrect preparation and administration, which may result in the recall of patients for re-vaccination
Regulatory & Reimbursement
If you want a broad listing, ask the patients
The PBAC has updated the guidelines for pharmas seeking multi-cancer listings, looking for information beyond the clinical
Latest
Leader flies a new flag for industry
After 30 years working in innovative medicine companies, the decision for Nikki Lorenz to become a champion of the generics and biosimilars industry was a surprisingly easy one
Regulation & Legal
No fine after 'disparaging a rival' investigation
While this pharma has staved off a potentially hefty fine, it has agreed to a tough, legally binding agreement after an EU antitrust case
Regulatory & Reimbursement
Gene therapy rollout: Australia next in line?
A US company is ramping up its Australian commercialisation efforts for a gene therapy that won the Best Product for Orphan Disease at the 2026 Prix Galien UK Awards
Featured
Troubled $33M drug withdrawn from Australia
Following reports of eight deaths overseas, allegations trial results were manipulated plus regulatory action in the UK and Europe, this drug is coming off the market
Patients
Advocates fight to keep Richard Scolyer’s vision alive
Exactly one year after the late Professor challenged Australia to bring the same ambition to brain cancer that helped transform advanced melanoma, advocates are back at Parliament House
Leadership & People
Aussie GM reveals success secrets in new book
GSK's Australian Country Leader Andrew Thomas tells how being open to 'taking a shot' created a global high-flying career and offers tips on how pharma professionals can get ahead, in a new book called Work Fame
Government & Policy
Fixing kids' medicine access in Australia
A UCB-sponsored report into the failings of paediatric medicine funding was launched in Parliament House today, attended by the heads of the Standing Committee on Health
Featured
Roadblock hits plans to shore up the world's biggest drug
A strategy to protect market share for this oncology juggernaut has run into a major roadblock overseas and the same legal hurdle could hit Australia too
Jobs
-
Regional Sales Manager New
-
Clinical Data Manager New
-
Corporate Accounts Lead New
-
Inventory Supervisor New
-
Market Access Lead New
-
Senior Clinical Research Associate (FSP) New
-
Senior Clinical Research Associate New
-
Senior Associate, Quality Assurance & Regulatory Affairs New
-
Customer Service & Claims Consultant | Healthcare New
-
QA Engineer New
Featured
Why 'job hugging' is risky in pharma
It's been a tough few years in pharma but this Australian recruitment expert warns that staying put in your current role just for job security is riskier than you think
Jobs & Workplace
Fresh starts dominate latest job moves
Talent movements across industry include a new role after redundancy, a move to a new country and leaving a company after 18 years
Pipeline & Intellectual Property
Launch on hold pending legal fight
This company has two generics ready to launch but has agreed to hold off ahead of a Full Federal Court hearing scheduled for next year in which a franchise worth $170M will be challenged
Awards
Aussie pioneer lands $50K Novo prize
Pioneering contributions to help eliminate malaria has earned this scientist Novo's coveted Young Women in Science Award plus $50K to continue her research
Regulation & Legal
J&J fails to exclude influencers in class action notice
A court has ruled the channels to inform the public of a class action against Johnson & Johnson can include influencers in order to reach as many people as possible
Awards
Award-winning campaign drives drug to 34% market share
This agency alongside its pharma client have been awarded Bronze in Health Marketing, a category that finally returned to this year’s Australian Effie Awards
Patients
Parliament House forum targets faster diagnosis
From 10 months to 10 weeks: national forum held at Parliament house looks to slash diagnosis time for juvenile arthritis in Australia
Government & Policy
Aussie kids missing out on cancer trials
New Medicines Australia white paper calls for reforms to open more potentially life-saving cancer trials to Australian children
- Government & Policy Meet the lobbyists shaping pharma's future
- Regulation & Legal Company dobs itself in for UK Code Breach
- Regulatory & Reimbursement Pharmas turn up the heat on Novartis
- Jobs & Workplace Company launches new leadership role
- Regulatory & Reimbursement Expanded funding for four diabetes drugs
- Industry & Companies Bayer sets challenge for next-gen innovators
- Jobs & Workplace Who's left? Senior pharma leaders on the move
- Leadership & People So that's where he's gone: GM lands new job
- Pipeline & Intellectual Property Drug dropped over manufacturing issues
- Pipeline & Intellectual Property Peter Mac spin-off starts life with $12M